| POLR2E |
POLR2E: DNA-directed RNA polymerases I, II, and III subunit RPABC1 |
POLR2L |
POLR2L: DNA-directed RNA polymerases I, II, and III subunit RPABC5 |
217.000 |
Evidence |
|
| POLR2B |
POLR2B: DNA-directed RNA polymerase II subunit RPB2 |
POLR2H |
POLR2H: DNA-directed RNA polymerases I, II, and III subunit RPABC3 |
217.000 |
Evidence |
O
|
| SYK |
SYK: Tyrosine-protein kinase SYK |
LCP2 |
LCP2: Lymphocyte cytosolic protein 2 |
217.000 |
Evidence |
|
| C1R |
C1R: Complement C1r subcomponent precursor |
C1S |
C1S: Complement C1s subcomponent precursor |
217.000 |
Evidence |
O
|
| CD3E |
CD3E, T3E: T-cell surface glycoprotein CD3 epsilon chain precursor |
CD3G |
CD3G, T3G: T-cell surface glycoprotein CD3 gamma chain precursor |
217.000 |
Evidence |
|
| EIF2S1 |
EIF2S1, EIF2A: Eukaryotic translation initiation factor 2 subunit 1 |
EIF2B2 |
EIF2B2, EIF2BB: Translation initiation factor eIF-2B subunit beta |
214.000 |
Evidence |
O
|
| RRM1 |
RRM1, RR1: Ribonucleoside-diphosphate reductase large subunit |
RRM2 |
RRM2, RR2: Ribonucleoside-diphosphate reductase subunit M2 |
213.000 |
Evidence |
O
|
| SOCS3 |
SOCS3, CIS3, SSI3: Suppressor of cytokine signaling 3 |
JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
209.000 |
Evidence |
O
|
| EGF |
EGF: Pro-epidermal growth factor precursor |
ERBB2 |
ERBB2, HER2, NEU, NGL: Receptor tyrosine-protein kinase erbB-2 precursor |
209.000 |
Evidence |
O
|
| EFNA2 |
EFNA2, EPLG6, LERK6: Ephrin-A2 precursor |
EPHA2 |
EPHA2, ECK: Ephrin type-A receptor 2 precursor |
209.000 |
Evidence |
O
|
| ORC5L |
ORC5L: Origin recognition complex subunit 5 |
ORC2L |
ORC2L, ORC2: Origin recognition complex subunit 2 |
207.000 |
Evidence |
O
|
| JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
STAT2 |
STAT2: Signal transducer and activator of transcription 2 |
206.000 |
Evidence |
|
| STAT5B |
STAT5B: Signal transducer and activator of transcription 5B |
SRC |
SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src |
206.000 |
Evidence |
|
| KIT |
KIT: Mast/stem cell growth factor receptor precursor |
BTK |
BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK |
206.000 |
Evidence |
|
| F2 |
F2: Prothrombin precursor |
SERPINE1 |
SERPINE1, PAI1, PLANH1: Plasminogen activator inhibitor 1 precursor |
206.000 |
Evidence |
|
| EIF4G2 |
EIF4G2, DAP5, OK/SW-cl.75: Eukaryotic translation initiation factor 4 gamma 2 |
EIF4A2 |
EIF4A2, DDX2B, EIF4F: Eukaryotic initiation factor 4A-II |
204.000 |
Evidence |
|
| NCK2 |
NCK2: Cytoplasmic protein NCK2 |
EGFR |
EGFR, ERBB1: Epidermal growth factor receptor precursor |
200.000 |
Evidence |
|
| JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
EGFR |
EGFR, ERBB1: Epidermal growth factor receptor precursor |
200.000 |
Evidence |
|
| PSMA5 |
PSMA5: Proteasome subunit alpha type-5 |
PLK1 |
PLK1, PLK: Serine/threonine-protein kinase PLK1 |
200.000 |
Evidence |
O
|
| PDGFRB |
PDGFRB: Beta-type platelet-derived growth factor receptor precursor |
STAT3 |
|
200.000 |
Evidence |
|
| FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
CBLB |
CBLB, RNF56, Nbla00127: E3 ubiquitin-protein ligase CBL-B |
200.000 |
Evidence |
|
| PDGFRA |
PDGFRA: Alpha-type platelet-derived growth factor receptor precursor |
STAT3 |
|
200.000 |
Evidence |
|
| EGFR |
EGFR, ERBB1: Epidermal growth factor receptor precursor |
STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
200.000 |
Evidence |
|
| FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
STAT1 |
STAT1: Signal transducer and activator of transcription 1-alpha/beta |
200.000 |
Evidence |
|
| PLK1 |
PLK1, PLK: Serine/threonine-protein kinase PLK1 |
PSMA3 |
PSMA3, PSC8: Proteasome subunit alpha type-3 |
200.000 |
Evidence |
O
|
